Conference Call and Webcast
Favrille's management team will host a conference call today at 8:30 a.m. Eastern Time to discuss the information contained in this press release. A live audio webcast will be available on the Investor Relations section of the Company's web site at http://www.favrille.com . Alternatively, callers may participate in the conference call by dialing (866) 831-6267 or (617) 213-8857, passcode 99549869. A telephone replay of the call will also be available for 48 hours. The telephone replay can be accessed by dialing (888) 286-8010 or (617) 801-6888, passcode 20389415.
About Favrille, Inc.
Favrille, Inc. is a biopharmaceutical company focused on the development and commercialization of targeted immunotherapies for the treatment of cancer and other diseases of the immune system.
Statements in this press release that are not strictly historical in
nature constitute "forward-looking statements." Such statements include,
but are not limited to, references to Favrille's product candidates,
proprietary technologies and research and clinical development programs.
Such forward-looking statements involve known and unknown risks,
uncertainties and other factors that may cause Favrille's actual results to
be materially different from historical results or from any results
expressed or implied by such forward-looking statements. These factors
include, but are not limited to, risks and uncertainties related to
Favrille's ability to continue its operations, conserve cash or recognize
value on our assets and additional risks discussed in Favrille's filings
with the Securiti
|SOURCE Favrille, Inc.|
Copyright©2008 PR Newswire.
All rights reserved